Imad Ajjawi

Corporate Officer/Principal at ABSCI CORPORATION

Consumer Services

Health Technology

Technology Services

Profile

Imad Ajjawi is the founder of Denovium, Inc. He currently works as the Vice President-Business Development at Absci Corp.
His education includes an MBA from the University of California San Diego and a doctorate from the University of Nevada.

Imad Ajjawi active positions

Companies	Position	Start
ABSCI CORPORATION	Corporate Officer/Principal	31/12/2020
Denovium, Inc. Denovium, Inc. Packaged SoftwareTechnology Services Part of Absci Corp., Denovium, Inc. is an American artificial intelligence company that pioneers novel AI methods to accelerate innovation in biology. Denovium is building an artificial intelligence engine (Denovium EngineTM) capable of interpreting disparate biological data types to answer biology's toughest questions. The company partners with leading biotech and pharma companies in specific areas of focus, including gene discovery, protein engineering, and genomic medicine. The company was founded by Toby H. Richardson, Ariel Schwartz, Imad Ajjawi, and Gregory Hannum, with Toby H. Richardson serving as the CEO since incorporation. Denovium was acquired by Absci Corp. on January 12, 2021 for $4 million.	Founder	-

All active positions of Imad Ajjawi

Training of Imad Ajjawi

University of California San Diego	Masters Business Admin
University of Nevada	Doctorate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Imad Ajjawi's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ABSCI CORPORATION	Health Technology

Private companies	1
Denovium, Inc. Denovium, Inc. Packaged SoftwareTechnology Services Part of Absci Corp., Denovium, Inc. is an American artificial intelligence company that pioneers novel AI methods to accelerate innovation in biology. Denovium is building an artificial intelligence engine (Denovium EngineTM) capable of interpreting disparate biological data types to answer biology's toughest questions. The company partners with leading biotech and pharma companies in specific areas of focus, including gene discovery, protein engineering, and genomic medicine. The company was founded by Toby H. Richardson, Ariel Schwartz, Imad Ajjawi, and Gregory Hannum, with Toby H. Richardson serving as the CEO since incorporation. Denovium was acquired by Absci Corp. on January 12, 2021 for $4 million.	Technology Services